Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
proteomics
Biotech
VantAI plays matchmaker for Halda's RIPTACs in $1B deal
Halda has inked a deal that could be worth more than $1 billion to secure a source of targets for its novel approach to oncology and immunology.
Nick Paul Taylor
Aug 19, 2025 8:00am
Illumina picks up proteomics developer SomaLogic for $425M
Jun 23, 2025 11:00am
Thermo Fisher collects green lights for $3.1B Olink takeover
Jul 8, 2024 10:25am
Protein parser Alamar Bio collects $128M for analyzer launch
Mar 1, 2024 10:58am
NanoString loses $31M patent verdict to 10x Genomics
Nov 20, 2023 4:15pm
Bruker taps into single-cell biology with $108M PhenomeX deal
Aug 21, 2023 12:55pm
